“Entrevista Samuel Sánchez / J.M.Mainat“
Search Results for:
IBEC Seminar: Prof. Shulamit Levenberg
Engineering Vascularized Tissue Constructs
IBEC Seminar: Prof. Shulamit Levenberg
Engineering Vascularized Tissue Constructs
The enzymes that enable bacteria to make themselves at home
IBEC researchers have come a step closer to understanding how bacteria can cause chronic infections by identifying the key enzymes that allow them to create the right conditions for infection.
When P. aeruginosa bacteria cause chronic lung infections in patients with cystic fibrosis or chronic obstructive pulmonary disease (COPD), it means they have been able to form a mature biofilm in situ that lets them grow and adapt. This biofilm not only enhances cell-to-cell communication for the bacteria, thus allowing the infection to increase and thrive, but it also increases the chances of developing new antibiotic resistance and escape from the body’s immune system.
IBEC Seminar: The new IBEC Bio-AFM system
The new IBEC Bio-AFM system: system’s performance, applications and users’ guide
IBEC Seminar: The new IBEC Bio-AFM system
The new IBEC Bio-AFM system: system’s performance, applications and users’ guide
Telenoticias Hospitalet: “El present i el futur de la Fibrosi Quística”
The news programme L’Informatiu in L’Hospitalet featured the Cystic Fibrosis event, “El present i el futur de la Fibrosi Quística”, that was organised by IBEC and the ACFQ on 27th April.
Analytical Chemist
Application Deadline: 20/05/2016
Ref: AC-SM
The Signal and information processing for sensing systems group at the Institute for Bioengineering of Catalonia (IBEC) is looking for a Analytical Chemist .
“Los ratones de laboratorio tienen frío, trasnochan y están demasiado limpios”
Yesterday La Vanguardia published a special report on animal experimentation in their ‘Big Vang’ science section.
IBEC signs agreement with Bioibérica
IBEC has signed a collaboration agreement with Bioibérica S.A., a company specialised in the R&D, production and sale of biomolecules and new technologies for the pharmaceutical, veterinary and agrochemical industries. It’s the latest success story in IBEC’s active pursuit of the establishment of research projects with industry partners who share its commitment to bringing high-quality health research and technologies to market and the patient.
Together, IBEC – specifically its Nanomalaria joint unit with ISGlobal, led by Xavier Fernández-Busquets – and Bioibérica, which since its formation in 1975 has focused on the investigation and production of biomolecules extracted from animal tissue with significant biological and therapeutic properties, will explore ways of combining their expertise to achieve advances in future medicine.